“…For this reason, tumor immunity is increasingly a target of research. The most important genetic component of the body's immune function is the major histocompatibility complex, and certain human leukocyte antigens (HLA) have been implicated in the development of squamous cell carcinoma (11–13), including both HLA class I and class II genotypes (14). Loss of heterozygosity of the HLA complex may provide tumor cells with a phenotype permitting immune escape (15).…”